← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:163 | 163 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-1 | Biotin | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:163 | 163 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-98 | Bevacizumab | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:163 | 163 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1028 | 73013-1028-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:163 | 163 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:163 | 163 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:163 | 163 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-151 | 69194-151-01 | Calcium Gluconate Monohydrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:163 | 163 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-152 | 69194-152-01 | Calcium Gluconate Monohydrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:164 | 164 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-504 | 65302-504-05 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:164 | 164 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:164 | 164 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:164 | 164 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:164 | 164 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Budesonide | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:164 | 164 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1661 | 5446-1661-13 | Bevacizumab | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:164 | 164 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:164 | 164 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-021 | 71506-021-56 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:164 | 164 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0407 | 72196-0407-1 | Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:164 | 164 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5084 | 26436-5084-3 | Biotin | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:164 | 164 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:164 | 164 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1004 | 73013-1004-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:164 | 164 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:164 | 164 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:164 | 164 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0418 | 71285-0418-1 | Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:164 | 164 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0418 | 71285-0418-1 | Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:165 | 165 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-165 | 82396-165-10 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:165 | 165 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:165 | 165 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:165 | 165 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:165 | 165 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Budesonide | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:165 | 165 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-589 | 72833-589-30 | Biotin | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:165 | 165 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:165 | 165 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-955 | 72833-955-25 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:165 | 165 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate; Calcium Saccharate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:165 | 165 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:165 | 165 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:165 | 165 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-933 | 69194-933-01 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:165 | 165 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:165 | 165 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:165 | 165 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0416 | 71285-0416-1 | Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Valine; Heparin Sodium | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:165 | 165 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0416 | 71285-0416-1 | Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Valine; Heparin Sodium | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:166 | 166 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-173 | 63037-173-25 | Phenylephrine HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:166 | 166 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:166 | 166 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:166 | 166 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:166 | 166 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9160 | 71266-9160-2 | Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:166 | 166 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-2 | Biotin | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:166 | 166 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-880 | 69852-880-10 | Brompheniramine Maleate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:166 | 166 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0014 | 81483-0014-0 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:166 | 166 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-102 | 71449-102-36 | Cantharidin | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:166 | 166 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:166 | 166 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8006 | 71266-8006-1 | Bevacizumab | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:166 | 166 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-803 | 69194-803-01 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:166 | 166 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-604 | 70092-604-47 | Cefazolin Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:166 | 166 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:166 | 166 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0422 | 72196-0422-1 | Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:166 | 166 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0422 | 72196-0422-1 | Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:167 | 167 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5001 | 26436-5001-5 | ASCORBIC ACID | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:167 | 167 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:167 | 167 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:167 | 167 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:167 | 167 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0004 | 81483-0004-0 | Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:167 | 167 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Biotin | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:167 | 167 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Budesonide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:167 | 167 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6019 | 71285-6019-1 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:167 | 167 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-131 | 73702-131-10 | Cefazolin | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:167 | 167 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:167 | 167 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bimatoprost | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:167 | 167 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5500 | 26436-5500-1 | Buprenorphine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:167 | 167 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-603 | 70092-603-46 | Cefazolin Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:167 | 167 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:167 | 167 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0649 | 26436-0649-3 | Carnitine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:167 | 167 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-510 | 83298-510-12 | Carboplatin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:168 | 168 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-11 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:168 | 168 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:168 | 168 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-43 | Bevacizumab | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:168 | 168 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:168 | 168 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0003 | 81483-0003-0 | Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:168 | 168 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Brolucizumab | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:168 | 168 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Budesonide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:168 | 168 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6118 | 71285-6118-1 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:168 | 168 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:168 | 168 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-880 | 69852-880-10 | Brompheniramine Maleate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:168 | 168 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9018 | 83826-9018-5 | Bimatoprost; Timolol Maleate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:168 | 168 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4365 | 72934-4365-3 | Calcipotriene; Clobetasol Propionate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:168 | 168 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-623 | 70092-623-03 | Cefazolin Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:168 | 168 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:168 | 168 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-132 | 73702-132-23 | Cefazolin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:168 | 168 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0649 | 26436-0649-3 | Carnitine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:169 | 169 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5343 | 26436-5343-1 | Estriol | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:169 | 169 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Avexitide | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:169 | 169 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-44 | Bevacizumab | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:169 | 169 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1557 | 5446-1557-01 | Bevacizumab-Awwb | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:169 | 169 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:169 | 169 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Brolucizumab | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:169 | 169 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Budesonide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:169 | 169 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-944 | 72833-944-12 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:169 | 169 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:169 | 169 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-880 | 69852-880-10 | Brompheniramine Maleate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:169 | 169 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bimatoprost; Timolol Maleate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:169 | 169 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0005 | 81483-0005-0 | Calcium Chloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:169 | 169 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-622 | 70092-622-03 | Cefazolin Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:169 | 169 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2433 | 72627-2433-3 | Cholecalciferol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:169 | 169 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-132 | 73702-132-10 | Cefazolin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:169 | 169 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:170 | 170 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5483 | 26436-5483-1 | ACH | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:170 | 170 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:170 | 170 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-35 | Bevacizumab | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:170 | 170 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0220 | 71283-0220-3 | Biotin | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:170 | 170 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-078 | 71449-078-51 | Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:170 | 170 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:170 | 170 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Budesonide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:170 | 170 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-738 | 72833-738-12 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:170 | 170 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:170 | 170 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9160 | 71266-9160-2 | Bupivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:170 | 170 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bimatoprost; Timolol Maleate; Brimonidine Tartrate; Dorzolamide Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:170 | 170 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-625 | 69194-625-01 | Calcium Chloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:170 | 170 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-5330 | 71139-5330-2 | Cefazolin Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:170 | 170 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cholecalciferol | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:170 | 170 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:170 | 170 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:171 | 171 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-014 | 70713-014-01 | TESTOSTERONE ANASTROZOLE SA2 200MG 20MG | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:171 | 171 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:171 | 171 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8005 | 71266-8005-2 | Bevacizumab | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:171 | 171 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-589 | 72833-589-30 | Biotin | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:171 | 171 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-970 | 69374-970-05 | Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:171 | 171 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:171 | 171 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-019 | 79926-019-10 | Budesonide | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:171 | 171 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-739 | 72833-739-50 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:171 | 171 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:171 | 171 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-970 | 69374-970-50 | Bupivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:171 | 171 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9003 | 83826-9003-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:171 | 171 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Chloride Anhydrous | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:171 | 171 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-7087 | 71139-7087-1 | Cefazolin Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:171 | 171 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cholic Acid | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:171 | 171 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:171 | 171 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:172 | 172 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0420 | 71285-0420-1 | Trophamine 3%/Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:172 | 172 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:172 | 172 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70360-001 | 70360-001-60 | Bevacizumab | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:172 | 172 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Biotin | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:172 | 172 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-970 | 69374-970-50 | Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:172 | 172 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:172 | 172 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9160 | 71266-9160-2 | Bupivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:172 | 172 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:172 | 172 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-132 | 73702-132-23 | Cefazolin | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:172 | 172 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-524 | 65302-524-10 | Bupivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:172 | 172 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-1 | Biotin | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:172 | 172 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0206 | 71285-0206-1 | Calcium Chloride; Sodium Chloride; Potassium Chloride; Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:172 | 172 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ceftazidime | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:172 | 172 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Choline Chloride; Inositol; Pyridoxine Hydrochloride; Methionine; Thiamine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:172 | 172 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:172 | 172 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:173 | 173 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-933 | 69194-933-01 | 933 BUPIVACAINE HCL 0.375%, LIDOCAINE HCl 2% SYRINGE | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:173 | 173 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:173 | 173 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70360-001 | 70360-001-02 | Bevacizumab | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:173 | 173 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Brilliant Blue G | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:173 | 173 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6001 | 71286-6001-1 | Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:173 | 173 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-880 | 69852-880-10 | Brompheniramine Maleate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:173 | 173 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:173 | 173 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-950 | 69374-950-10 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:173 | 173 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-132 | 73702-132-10 | Cefazolin | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:173 | 173 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-525 | 65302-525-10 | Bupivacaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:173 | 173 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Biotin | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:173 | 173 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:173 | 173 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-555 | 69194-555-01 | Cefuroxime Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:173 | 173 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6422 | 72682-6422-1 | Choline Chloride; Methionine; Inositol; Cyanocobalamin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:173 | 173 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:173 | 173 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-132 | 73702-132-10 | Cefazolin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:174 | 174 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-014 | 71506-014-58 | Vancomycin Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:174 | 174 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:174 | 174 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:174 | 174 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Brolucizumab | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:174 | 174 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-067 | 70713-067-05 | Bupivacaine Hydrochloride Anhydrous | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:174 | 174 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3319 | 62295-3319-7 | Brompheniramine Maleate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:174 | 174 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:174 | 174 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:174 | 174 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-2011 | 70214-2011-1 | Cefazolin | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:174 | 174 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:174 | 174 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5084 | 26436-5084-3 | Biotin | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:174 | 174 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:174 | 174 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cholecalciferol | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:174 | 174 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7555 | 72934-7555-6 | Ciclopirox Olamine; Clobetasol Propionate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:174 | 174 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:174 | 174 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-132 | 73702-132-23 | Cefazolin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:175 | 175 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4602 | 72934-4602-8 | Hevona | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:175 | 175 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:175 | 175 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1508 | 5446-1508-01 | Bevacizumab | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:175 | 175 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Brolucizumab | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:175 | 175 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-068 | 70713-068-05 | Bupivacaine Hydrochloride Anhydrous | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:175 | 175 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6001 | 71286-6001-1 | Bupivacaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:175 | 175 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:175 | 175 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:175 | 175 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-2013 | 70214-2013-1 | Cefazolin | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:175 | 175 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-269 | 70092-269-37 | Bupivacaine Hydrochloride Anhydrous; Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:175 | 175 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1396 | 72934-1396-2 | Brimonidine Tartrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:175 | 175 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:175 | 175 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Choline Chloride; Inositol; Pyridoxine Hydrochloride; Methionine; Thiamine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:175 | 175 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7557 | 72934-7557-6 | Ciclopirox Olamine; Salicylic Acid | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:175 | 175 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-131 | 73702-131-10 | Cefazolin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:175 | 175 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:176 | 176 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-377 | 73693-377-01 | ESTRADIOL 12.5MG | 2025-1 | valid | 0 | 2026-09-18 |